SEVERANCE AGREEMENT AND GENERAL RELEASESeverance Agreement and General Release • March 6th, 2009 • Biocryst Pharmaceuticals Inc • Biological products, (no disgnostic substances)
This SEVERANCE AGREEMENT AND GENERAL RELEASE (“Agreement”) is made and entered into by Michael Darwin (“Employee”) and BioCryst Pharmaceuticals, Inc. (“the Company”).
FIRST AMENDMENT TO LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENTDevelopment and Commercialization Agreement • March 6th, 2009 • Biocryst Pharmaceuticals Inc • Biological products, (no disgnostic substances) • New York
This First Amendment (this “Amendment”) to the License, Development and Commercialization Agreement between BioCryst Pharmaceuticals, Inc. (“BioCryst”) and Shionogi & Co., Ltd. (“Shionogi”), dated as of February 28, 2007 (the “Agreement”), shall be effective as of September 30, 2008 (the “First Amendment Date”).
